Therapeutic Asset Ratings
141 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
gm1
Stroke
Xuanwu Hospital, Beijing
P4
B
(56)
Lacosamide
Stroke
University of North Carolina, Chapel Hill
P4
B
(56)
NORADRENALINE TARTRATE IMPURITY C
Stroke
Singapore General Hospital
P4
B
(56)
PROSTAGLANDIN E1
Stroke
The First Hospital of Jilin University
P4
B
(56)
Prothrombin Complex Concentrate, Human
Stroke
Region Skane
P4
B
(56)
Prourokinase
Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
B
(56)
RETEPLASE, RECOMBINANT
Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
B
(56)
Evolocumab
Stroke
Amgen
P4
CCC
(55)
Fresh Frozen Plasma
Stroke
Region Skane
P4
CCC
(55)
Valproic Acid
Stroke
University of North Carolina, Chapel Hill
P4
CCC
(55)
DESFERRIOXAMINE B
Stroke
The George Institute
P3
CCC
(55)
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION
Stroke
Zhujiang Hospital
P3
CCC
(55)
Nicardipine
Stroke
Zeenat Qureshi Stroke Institute
P2
CCC
(55)
INDAPAMIDE
Stroke
Beijing Tiantan Hospital
P4
CCC
(54)
17-beta-estradiol
Stroke
Imperial College London
P3
CCC
(54)
Clevidipine
Stroke
Zeenat Qureshi Stroke Institute
P3
CCC
(54)
Fuzuloparib
Stroke
Centre National de Rééducation Fonctionnelle et de Réadaptation
P3
CCC
(54)
RAMIFENTANYL
Stroke
University Hospital Heidelberg
P3
CCC
(54)
Succinic Acid)
Stroke
POLYSAN Scientific & Technological Pharmaceutical Company
P3
CCC
(54)
Zeprumetostat
Stroke
Centre National de Rééducation Fonctionnelle et de Réadaptation
P3
CCC
(54)
Adipose Derived Stem Cell
Stroke
University Hospital, Grenoble
P2/3
CCC
(54)
Maraviroc
Stroke
Emmanuel Carrera
P2/3
CCC
(54)
Fosphenytoin
Stroke
University of North Carolina, Chapel Hill
P4
CCC
(52)
Adezunap
Stroke
Apurano Pharmaceuticals GmbH
P3
CCC
(52)
Chirocaine
Stroke
Institut National de la Santé Et de la Recherche Médicale, France
P3
CCC
(52)
Showing 51 to 75 of 141 assets
Previous
Page 3 of 6
Next
